Implementation of Whole Genome Sequencing as Screening in a Diverse Cohort of Healthy Infants

NARecruitingINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

December 21, 2022

Primary Completion Date

February 1, 2025

Study Completion Date

July 1, 2025

Conditions
Genetic Predisposition to DiseaseHereditary Diseases
Interventions
GENETIC

Genome Sequencing

20 times read depth (20x) next-generation whole genome sequencing with comprehensive analysis.

Trial Locations (4)

10029

RECRUITING

Icahn School of Medicine at Mount Sinai, New York

35294

RECRUITING

University of Alabama at Birmingham, Birmingham

48073

RECRUITING

Beaumont - Corewell Health East, Royal Oak

02115

RECRUITING

Boston Children's Hospital, Boston

All Listed Sponsors
collaborator

Baylor College of Medicine

OTHER

collaborator

Boston Children's Hospital

OTHER

collaborator

Broad Institute of MIT and Harvard

OTHER

collaborator

Dartmouth-Hitchcock Medical Center

OTHER

collaborator

Harvard Pilgrim Health Care

OTHER

collaborator

Howard University

OTHER

collaborator

HudsonAlpha Institute for Biotechnology

OTHER

collaborator

Massachusetts General Hospital

OTHER

collaborator

Icahn School of Medicine at Mount Sinai

OTHER

collaborator

University of Alabama at Birmingham

OTHER

collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Brigham and Women's Hospital

OTHER